Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
D000279:Administration, Cutaneous; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005227:Fatty Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D007169:Impetigo / Q000188:drug therapy*; D016712:Mupirocin
D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D016712:Mupirocin